Trump’s drug price policy fuels UK surge as Mounjaro bills set to triple
Eli Lilly, the US manufacturer of Mounjaro, has instructed its two British wholesalers to stop taking orders amid “unprecedented demand,” which is believed to be driven by Brits eager to avoid next week’s price increase - which could be as high as 170%.
This means that pharmacies, which have already been reporting ‘Covid-style’ panic-buying of the product in recent weeks, will not be able to request more Mounjaro until the significant price hike takes effect on September 1st.
Earlier this month, Eli Lilly announced that the cost of the jab would increase starting September. This decision followed shortly after US President Donald Trump revealed plans to lower domestic drug prices by encouraging America’s drug manufacturers to raise their prices in markets such as the UK.
This means that users on the highest dose of the medicine could see their monthly bills rise from £122 to £330.
The result has been a surge in people looking to stockpile the drug.
In a letter to pharmacies across the UK, one distributor - PHOENIX - stated: “Following recent news regarding Mounjaro and the upcoming price change effective 1st September, PHOENIX is currently experiencing a significant surge in demand.
“Eli Lilly [has therefore] requested that we implement an order freeze on Mounjaro products for all customers from the end of the day, 27th August.”
Read more similar news:
Comments:
comments powered by Disqus
